fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

CE Mark approved in Europe for the Volt PFA system to treat patients with atrial fibrillation – Abbott

Written by | 4 Apr 2025

Abbott announced it has received CE Mark in Europe for the Volt PFA System to treat patients battling atrial fibrillation (AFib). With the earlier-than-expected CE Mark, Abbott has… read more.

Risk of dementia increases with mid-life AF diagnosis

Written by | 3 Apr 2025

Researchers report a significantly increased risk of dementia in patients diagnosed with atrial fibrillation (AF) in midlife, and a significantly increased risk of early-onset dementia (EOD) as well…. read more.

Bleeding risks vary among atrial fibrillation treatments

Written by | 11 Feb 2025

A meta-analysis evaluating bleeding risks among atrial fibrillation (AF) patients treated with therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) indicates that rates of major… read more.

240-year-old drug could save UK National Health Service £100 million a year treating common heart rhythm disorder

Written by | 7 Feb 2025

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure. … read more.

Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation

Written by | 21 Jan 2025

Boston Scientific Corporation (announced data supporting the use of the FARAPULSE Pulsed Field Ablation (PFA) System  during a late-breaking science session at AF Symposium 2025. Currently, the FARAPULSE… read more.

FDA approval of Varipulse Platform to treat refractory paroxysmal atrial fibrillation – J&J Med Tech

Written by | 13 Nov 2024

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, announced the FDA approval of the Varipulse  Platform for the treatment of drug refractory paroxysmal Atrial Fibrillation… read more.

Smoking cessation lowers risk of AFib

Written by | 14 Sep 2024

Smoking cessation can significantly reduce a person’s risk of developing atrial fibrillation compared to those who continue smoking. Researchers reported this finding on Sept. 11 in JACC: Clinical… read more.

UCalgary study identifies a key role for pharmacists in stroke risk reduction

Written by | 7 Aug 2024

Atrial fibrillation (Afib) is the most common heart rhythm disorder encountered in clinical practice according to Dr. Roopinder Sandhu, MD, MPH, and the leading cause of stroke in… read more.

Affera Mapping and Ablation System with Sphere-9 catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment – Medtronic

Written by | 31 May 2024

Medtronic plc , announced positive results demonstrating excellent safety and efficacy of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one pulsed field (PF) and radiofrequency… read more.

Safety of switching from a Vitamin K antagonist to a non–Vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation

Written by | 8 May 2024

FRAIL-AF trial investigators set out to study the question of whether frail, elderly patients with atrial fibrillation who were doing well with vitamin K antagonists (VKA) should be… read more.

Engaging pharmacists to improve atrial fibrillation care

Written by | 26 Apr 2024

Atrial fibrillation, or AFib, is the most common type of irregular heartbeat, estimated to affect about 12.1 million U.S. adults by 2030.[1] The abnormal firing of electrical impulses causes… read more.

Atrial fibrillation linked to sweetened beverage use

Written by | 10 Mar 2024

Adults who consume two liters (about 67 ounces) or more of sugar- or artificially sweetened drinks per week are at a significantly higher risk of developing atrial fibrillation,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.